TAG:
the clinical laboratory
CPI Lab Fee Adjustment Threatened by New Bill
By Robert Michel | From the Volume IX No. 8 – June 3, 2002 Issue
CEO SUMMARY: Once again, the laboratory testing industry has been singled out as a healthcare “whipping boy” by Congressional aides. In working to develop the next federal budget, legislators again propose to deny annual CPI price updates for laboratory tests. This won’t be anything…
THE DARK REPORT’S Annual Ranking of Public Laboratory Companies
By Robert Michel | From the Volume IX No. 7 – May 13, 2002 Issue
Boom times continued during 2001 for both the clinical laboratory industry and anatomic pathology profession. Throughout 2001, almost every public lab company was able to post double-digit revenue growth. For a number of companies, this growth was accomplished b…
Why Can’t Hospital Laboratories Collaborate?
By R. Lewis Dark | From the Volume IX No. 4 – March 11, 2002 Issue
MOST PEOPLE KNOWLEDGEABLE ABOUT THE INNER WORKINGS of the clinical laboratory industry generally agree that hospital laboratories possess inherent advantages over commercial laboratories—anytime a hospital lab outreach program is organized properly and marketed professionally. Certainly the manage…
Pathology Part A Comp Under Attack by Both Hospitals and Insurers
By Robert Michel | From the Volume IX No. 4 – March 11, 2002 Issue
CEO SUMMARY: In steadily-growing numbers, hospitals and insurers are taking active steps to reduce or eliminate compensation for clinical pathology professional services, also commonly referred to as “Part A” services. Unfortunately, many pathology groups fail to anticipate this situati…
Lab Automation Subject Of “How To” Program
By Robert Michel | From the Volume IX No. 3 – February 18, 2002 Issue
CEO SUMMARY: Mastering lab automation is more difficult than it appears. The first-ever “Lab Automation Boot Camp” is assembling experienced lab administrators who have experience (and scars) in automation and are committed to telling the real story about making automation successful….
Patent Access Limits Rapid HIV Testing in USA
By Robert Michel | From the Volume IX No. 1 – January 7, 2002 Issue
CEO SUMMARY: Diagnostic manufacturers will begin to face the same controversy over public access to diagnostic testing technology that has dogged pharmaceutical companies in recent years. Public health officials and the military are unhappy with how Bio-Rad and its HIV-2 licensees have fa…
2001’s Ten Big Stories Presage Future Direction
By Robert Michel | From the Volume VIII No. 17 – December 17, 2001 Issue
CEO SUMMARY: During 2001, few labs found themselves under intense pressure to change or react to dramatic events in the healthcare marketplace. Like 2000, this past year was marked by evolutionary progress, not revolutionary change. However, continuing signs indicate that consumers will p…
Beckman Coulter Positions Itself For Biotech Testing Continuum
By Robert Michel | From the Volume VIII No. 16 – November 26, 2001 Issue
CEO SUMMARY: Here’s a little-known side to diagnostics giant Beckman Coulter Inc. Its efforts to expand into the fields of biomedical R&D and clinical research is a strategic shift designed to give it early access to promising technology that could be introduced into the clinical di…
Nation’s Anthrax Cases Bring Bioterror to Labs
By Robert Michel | From the Volume VIII No. 14 – October 15, 2001 Issue
CEO SUMMARY: America’s clinical laboratories are soon to be enlisted in the war against terrorism. Concerns about chemical and biological terrorist attacks have reached high levels following the death of a Florida man from pulmonary anthrax and the discovery of letters containing anthra…
“September 24, 2001 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VIII No. 13 – September 24, 2001 Issue
Many different professions lost good people as a result of the terrorist attack on the World Trade Center in New York City on September 11. However, the clinical laboratory industry and the pathology profession seems to have emerged unscathed. Following many conversations with laboratorians throughou…
CURRENT ISSUE

Volume XXXII, No. 13 – September 15, 2025
The Dark Report examines a new bill that would reform PAMA and avoid reimbursement rate cuts scheduled for January 2026. Clinical laboratory leaders are urged to make their voices heard in Congress. Also, an expert describes how labs can fix pre-analytical errors and avoid disaster.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized